[Drugs with effect on the adrenergic nerve fiber].
D000614:Aminocaproates / Q000494:pharmacology; D000639:Amitriptyline / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D001949:Bretylium Compounds / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004221:Disulfiram / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004809:Ephedrine / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D001523:Mental Disorders / Q000188:drug therapy; D008680:Metaraminol / Q000494:pharmacology; D008750:Methyldopa / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009474:Neurons / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D009655:Octopamine / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000378:metabolism; D013566:Sympathomimetics / Q000494:pharmacology* / Q000627:therapeutic use; D013747:Tetrabenazine / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology; D014652:Vascular Diseases / Q000188:drug therapy
D000614:Aminocaproates; D001949:Bretylium Compounds; D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D013566:Sympathomimetics; D009655:Octopamine; D000639:Amitriptyline; D008750:Methyldopa; D008680:Metaraminol; D012110:Reserpine; D000661:Amphetamine; D004809:Ephedrine; D011299:Prenylamine; D007099:Imipramine; D004221:Disulfiram; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D013747:Tetrabenazine; D006145:Guanethidine
Pharmaka mit Wirkung an der adrenergen Nervenfaser.